Thursday, November 5 represented the worst trading session for the U.S. market in over a year. the Nasdaq Composite dropped 5.52%, the S&P 500 fell 4.36%, and the Dow shed 3.44%, as Wall Street’s post-midterm optimism could not last long. Concerns around a potential weakness in AI spending reversed the post-election rally and led to almost $2.5 trillion wiped out of the U.S. market.
In the middle of this chaos, many names showed resistance and are still trading at their all-time highs. In our recent list of 10 Best All-Time High Stocks to Buy According to Wall Street, we uncover some of the stocks that still offer captivating upside to investors.
Various market sectors took a hit, including semiconductors which got affected the most. Technology was also amongst the worst-performing segments, dipping almost 8%. Just two days prior to the November 5 crash, we covered Warren Buffett’s list of the 10 best stocks with attractive upside potential.
Situations like this trigger fear within the market. But for corporate insiders, including company executives and directors, it offers attractive entry points. These insiders have a more detailed understanding of their businesses compared to investors and analysts. They know about a company’s growth prospects, margin potential, and product pipelines way before the market does.
Hence, a drop in share price does not necessarily mean that their stance on the company’s outlook would also change. Through open-market purchases out of their own pockets, the insiders send some clear signals to the market. Unlike stock awards or option exercises, these purchases come out of personal savings, and no one is forced to make them.
To identify relevant stocks for this article, we explored Insider Monkey’s insider-purchase database for the U.S.-listed companies with market capitalization above $1 billion. We narrowed down our search to stocks with a 1-month share price decline of more than 20%, as of November 6. Finally, we shortlisted stocks with insider purchase values above $50,000 from October 6 to November 6, and ranked stocks in an ascending order of their purchase values. Our selection excludes stock awards and option exercises from the qualifying purchases.
Pampa Energy Inc. (NYSE:PAM) recently hit its new 52-week low, as the stock has dropped by almost 26% in 2026. Despite its robust operational metrics, the company’s capital-intensive investment cycle triggered such a massive sell-off, as it missed the cash flow forecasts. Financing its $900 million electrical infrastructure ambitions for a 500 MW Patagonia data center buildout adds to the concerns.
The company has yielded almost 26% profit margin over the last twelve months, and that makes its trailing earnings multiple of 5.13x highly compelling. However, negative free cash flows due to large scale spending on projects such as Rincón de Aranda shale oil development and Fértil Pampa urea plant, have resulted in growing skepticism.
Vice President, Miguel Damian Mindlin, bought 38,652 American Depository Shares of Pampa Energy on November 3 and 4. He spent a total of $2,616,098 at an average purchase price of $67.68, bringing his total position to 729,545 shares. The purchase equates to a 5.6% increase in his holdings (see the history of insider purchases in PAM).
Data tracked across 1,000+ hedge funds by Insider Monkey reveals an increasing number of smart money managers invested in the company. As per 13F filing data for Q2 2026, a total of 15 hedge funds held positions in the stock compared to 12 by the end of the first quarter.
Applied Digital Corp. (NASDAQ:APLD) was amongst the names that saw a major sell-off amid regulatory restrictions on new data center approvals across Texas. The situation does not bode well for AI data center and neo-cloud operators. Applied Digital has dropped almost 32% year-to-date, as investors appear to be rotating away from debt-laden AI buildout plays.
The company’s existing debt of around $6.4 billion is not supported by its smaller cash base. This signals toward additional borrowings to supports its 800+ megawatt (MW) capacity ramp. Despite the concerns, the stock ranked #8 in our list of 10 Best 52-Week Low NASDAQ Stocks to Buy According to Billionaires, as bulls focus on the contracts behind the build.
President and Co-founder, Gechen Jason Zhang, recently raised his position in the stock by almost 12%. He bought 300,000 shares of common stock at a price of $18.86, paying a total consideration of $5,658,000. Following this purchase, his total holdings in Applied Digital clock in at 2,839,227 shares.
Based on data tracked across 1,000+ hedge funds by Insider Monkey, institutional sentiment toward the company remains strong. According to 13F filing data, number of smart-money managers with long-term exposure in the stock has been going up. A total of 59 hedge funds held positions by the end of Q2 2026, compared to 39 in Q1 2026.
Intel is undergoing a strategic shift from its position as a conventional integrated device manufacturer to a contract foundry. Hence, its success going forward rests on securing key external customers for its leading-edge nodes such as the Intel 18A and the upcoming 14A capability. It ranked #9 in our recent list of 10 Best Growth Stocks to Buy Now According to Billionaires.
The prevailing valuation multiples appear demanding for a company still going through a restructuring. The stock trades at a forward earnings multiple of 63.29x, which is clearly on the high side. The topline metrics captivate investor interest, as the price-to-sales ratio sits at 10.55 and the EV/Revenue multiple has clocked in at just 11.73. These readings highlight how the market is looking well past current earnings and betting more on expected improvements within Intel’s foundry business and product suite.
CEO Lip-Bu Tan bought 150,000 common shares at $64.73 on November 2, spending $9,709,680. This represented more than 11% increase in his position in Intel, which jumped from 1,314,669 to 1,464,669 shares (see the history of insider purchases in INTC).
Data tracked across 1,000+ hedge funds by Insider Monkey still shows significant amount of institutional interest in the stock. As per 13F filings, hedge fund ownership went up from 112 funds in Q1 2026 to 138 funds in the following quarter.
Galaxy Digital Inc. (NASDAQ:GLXY) has seen a reversal from its recent 52-week low of $11.78, but the stock is still down roughly 34% in 2026. It has been subject to a broader market correction across AI and data center segments. Significant debt exposure and investor concerns regarding its unleased capacity have weighed heavily on the underlying sentiment.
However, Galaxy’s core segments continue to offer encouragement as they target growing institutional demand trends for crypto adoption and AI compute workloads. Its digital assets platform delivers trading, lending, custody, and crypto-asset management solutions to institutional clients. On the other hand, its infrastructure platform operates data centers across West Texas to facilitate AI and HPC functions.
On November 5, CEO Michael Novogratz purchased a total of 760,000 shares of class A common stock for a total value of $9,864,346. You can see the history of insider purchases in GLXY here.
Institutional interest across 1,000+ hedge funds tracked by Insider Monkey shows an increase in exposure to the stock. According to 13F filing data, total number of hedge funds that held positions in the stock jumped to 45 by the end of second quarter in 2026, relative to 40 in Q1.
Share price of Rapport Therapeutics Inc. (NASDAQ:RAPP) dropped following a $350 million multi-part capital raise, involving discounted common shares and convertible note offerings. The company priced around 175 million in common stock at $21 per share, equating to a sharp 24% discount to the market price. Additionally, the company announced data for the Phase 2 bipolar mania trial of its lead candidate RAP-219.
Despite hitting its primary endpoint, the trial data exhibited a low 3.1-point edge compared to a placebo. This was in addition to a higher-than-anticipated discontinuation and agitation rates, which resulted in target price cuts by many analysts. However, the bullish narrative for the stock is backed by expansion of RAP-219 into high-value central nervous system indications. These include acute bipolar mania as well as the planned diabetic peripheral neuropathic pain.
On October 28, director James Healy accumulated 969,480 additional common shares of Rapport at an average price of $21. He spent a total of $20,359,080 to increase his holdings by more than 52%, from 1,846,227 to 2,815,707 common shares (see the history of insider purchases in RAPP).
Data tracked across 1,000+ hedge funds by Insider Monkey reveals a marginal increase in the number of smart money managers invested in the company. As per 13F filing data for Q2 2026, a total of 24 hedge funds held positions in the stock compared to 22 by the end of the first quarter.
While we acknowledge the risk and potential of RAPP as an investment, we believe certain AI infrastructure stocks offer far stronger long-term potential at a much more attractive entry point. If you are looking for an AI stock more promising than RAPP that operates as a critical AI tollbooth and stands as the most important company in the world, check out our report about this must-own AI stock.
